1. Home/
  2. Compounds/
  3. navitoclax:birinapant (1:1 mol/mol)

navitoclax:birinapant (1:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2navitoclax:birinapant (1:1 mol/mol)
PharmacoGx navitoclax:birinapant (1:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to navitoclax:birinapant (1:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA HDLBP CTRPv2 pan-cancer AAC -0.18 6e-06
mRNA NDUFS2 CTRPv2 pan-cancer AAC -0.18 7e-07
mRNA MTIF2 CTRPv2 pan-cancer AAC -0.18 2e-06
mRNA SUCLG2 CTRPv2 pan-cancer AAC -0.18 2e-06
mRNA NFS1 CTRPv2 pan-cancer AAC -0.18 9e-07
mRNA ATIC CTRPv2 pan-cancer AAC -0.18 2e-06
mRNA PFDN2 CTRPv2 pan-cancer AAC -0.18 1e-06
mRNA SUCLG1 CTRPv2 pan-cancer AAC -0.18 7e-07
mRNA DHODH CTRPv2 pan-cancer AAC -0.18 2e-06
mRNA SPR CTRPv2 pan-cancer AAC -0.18 4e-05
Download CSV